Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can when you eat beat metabolic syndrome? new study tests a dual approach

NCT ID NCT07389603

Disease control Sponsor: University of Guadalajara Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether limiting when you eat (to an 8- or 10-hour window each day) plus a special counseling program can improve health in people with metabolic syndrome. Researchers in Mexico will enroll 64 adults and track changes in waist size, blood pressure, blood sugar, and cholesterol over 8 weeks. The goal is to see if adding psychological and nutritional support helps people stick with the eating plan and get better results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Time-restricted eating and psychochrononutritional counseling
What this could lead to
If it works, this could point toward a practical, non-drug way to manage metabolic syndrome and reduce the risk of diabetes and heart disease.
What could go wrong
This is a small, early-stage trial with only 64 participants. The results may not apply to everyone, and sticking to the eating schedule can be hard for some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 60 years * Both sexes * Feeding window ≥14 h/day * Usual sleep duration \>6.5 h * Individuals diagnosed with metabolic syndrome who meet three or more of the criteria from Panel III of the National Cholesterol Education Program's Adult Treatment Guidelines: * Waist circumference: ≥102 cm for men, ≥88 cm for women * Triglycerides: ≥150 mg/dL or on treatment for hypertriglyceridemia * High-Density Lipoprotein (HDL) cholesterol: \<40 mg/dL for men, \<50 mg/dL for women * Blood pressure: systolic ≥130 mmHg and diastolic ≥85 mmHg or on treatment for hypertension * Fasting plasma glucose: ≥100 mg/dL * Individuals who provide informed consent Exclusion Criteria: * (based on participant self-report unless medical records are available) * Pregnancy or lactation * Currently enrolled in a weight loss program * Current treatment with antidepressants, medications that affect glucose metabolism or appetite, or immunosuppressant therapy * History or presence of eating disorders * Sleep apnea Elimination Criteria: * Participants who do not attend more than two sessions of the psychochrononutritional intervention program. * Participants who decide to withdraw their consent to continue in the study at any time for any reason.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Feeding Behavior Intermittent Fasting metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro Universitario del Sur

    RECRUITING

    Ciudad Guzmán, Jalisco, 49000, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.